(Reuters) – A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson’s COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
(Reporting by Manojna Maddipatla in Bengaluru, Editing by Franklin Paul)
